Abstract
Background PM2.5 concentrations vary between countries with similar CO2 emissions, possibly due to differences in air pollution control efficacy. However, no indicator of the level of air pollution control efficacy has yet been developed. We aimed to develop such an indicator, and to evaluate its global and temporal distribution and its association with country-level health metrics.
Method A novel indicator, ground level population-weighted average PM2.5 concentration per unit CO2 emission per capita (PM2.5/CO2, written as PC in abbreviation), was developed to assess country-specific air pollution control efficacy. We estimated and mapped the global average distribution of PC and PC changes during 2000–2016 across 196 countries. Pearson correlation coefficients and Generalized Additive Mixed Model (GAMM) were used to evaluate the relationship between PC and health metrics.
Results PC varied by country with an inverse association with the economic development. PC showed an almost stable trend globally from 2000 to 2016 with the low income groups increased. The Pearson correlation coefficients between PC and life expectancy at birth (LE), Infant-mortality rate (IMR), Under-five mortality rate (U5MR) and logarithm of GDP per capita (LPGDP) were –0.566, 0.646, 0.659, –0.585 respectively (all P-values <0.001). Compared with PM2.5 or CO2, PC could explain more variation of LE, IMR and U5MR. The association between PC and health metrics was independent of GDP per capita.
Conclusions PC might be a good indicator for air pollution control efficacy and was related to important health indicators. Our findings provide a new way to interpret health inequity across the globe from the point of air pollution control efficacy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by Taishan Scholar Program. CH was supported by Shandong provincial department of education funded projects for overseas study; SL was supported by an Early Career Fellowship of the Australian National Health and Medical Research Council (number APP1109193); and YG was supported by Career Development Fellowships of the Australian National Health and Medical Research Council (numbers APP1163693).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Declaration of competing interests The authors declare they have no actual or potential competing financial interests.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available upon request from the authors.
